An interventional study of Group Intervention in Autism, sponsored by University of Wisconsin, Madison. Recruiting at 1 site in United States. Per ClinicalTrials.gov, last updated 2026-10-05.
Sponsored by University of Wisconsin, Madison · Not applicable, Interventional, and Supportive care
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 604 studies in Autistic Disorder with a site in United States — 123 open to participants now, 152 under way, 3 of them phase 3. Autistic Disorder · United States.
Among the 604 studies in Autistic Disorder with a site in United States, this one is the 218th largest by planned enrollment of the 505 interventional ones that give a count, is one of 47 that started in 2026, is one of 296 with no phase, reaches primary completion later than 64 of the 150 other live ones, and was the 601st registered.
1,035 studies on the registry are indexed under Autistic Disorder; 270 are open to participants now.
Browse Autistic Disorder studies →123 of the 604 studies in Autistic Disorder with a site in United States are open now. Recruiting first, the newest first:
Children's Mercy Hospital Kansas City · Sites in United States
Ages 8–12
Northeastern University · Sites in United States
Ages 33 mo–71 mo
Vanderbilt University Medical Center · Sites in United States
Ages 36 mo–72 mo
Massachusetts General Hospital · Sites in United States
Ages 7–17
Stony Brook University · Sites in United States
Ages 12–17
A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →
Of the 184 Autistic Disorder studies recruiting now, 33 (18%) set no upper age limit and 144 (78%) stop at 75 or younger; 150 take children under 18; 56 take healthy volunteers.
This study: all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
604 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 55 · Phase 2 122 · Phase 3 43 · Phase 4 18
First in 1997; this study’s year is marked. 47 started in 2026.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 50 is close to the median of 50 across 814 interventional studies indexed under Autistic Disorder.
Median enrollment 44 across the 505 interventional studies, 135 across the 96 observational. Of the 409 that completed or were terminated, 143 (35%) have results posted.
This tab as a report to print or save as PDF → With an account.
73 of 604 have an industry lead sponsor. The 10 most frequent:
University of Wisconsin, Madison is the lead sponsor of 1,190 studies on the registry; 181 are open to participants now.
Of its 157 completed or terminated interventional studies of FDA-regulated products, 118 (75%) have results posted.
University of Wisconsin, Madison has 4 studies filed under Autistic Disorder — fewer than ten, so there is no comparison to draw.
34 of the studies in Autistic Disorder with a site in United States that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT02914951Yale UniversityCognitive-Behavioral Therapy for Irritability in Children With Autism Spectrum Disorder and Intellectual Disability | 2026-12 |
| NCT06627205Stanford UniversitySleep Restriction Therapy (SRT) for Sleep Problems in Children With Autism | 2026-12 |
| NCT04805957Rutgers, The State University of New JerseyValidation Digital Bio-markers During Sulforaphane Treatment. | 2026-12-01 |
| NCT07421830Northeastern UniversityAn Empowering Parent Training Intervention to Increase Physical Activity in Preschool Aged Children With Autism | 2026-12-31 |
| NCT02000284University of ArkansasMitochondrial Dysfunction in Autism Spectrum Disorder | 2026-12-31 |
Add all 34 to your calendar (.ics) → With an account.
Among the 604 studies in Autistic Disorder with a site in United States, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This study is a caregiver support program for family caregivers of autistic young adults (ages 18 to 26) as their family members navigate young adulthood. The program includes six 60-minute virtual sessions focused on making sense of caregiving roles during young adulthood, reflecting on everyday family experiences, supporting decision-making within families, deciding when and how to share experiences with others, and thinking about the future.
This program has three components:
For the six sessions, this program utilizes a peer-facilitated model, recognizing the unique expertise that comes from lived experience. Some aspects of navigating transition can only be fully understood and effectively communicated by fellow family caregivers, rather than by professionals.
Attendees are encouraged to bring their broader life experiences, including those unrelated to caregiving, when they see these experiences as central to who they are. The program welcomes participants as whole people, honoring both their caregiving role and the parts of their lives that extend beyond it.
Session content and topics are built from a series of interviews with family caregivers. The program not only covers what was openly discussed in those interviews but also explores what was less visible, what may have been unspoken, hidden, or missing from the conversations.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Family Caregivers of Autistic Young Adults
Other: Group Intervention
Six 60-min virtual sessions Surveys before and after program intervention Optional post-intervention interview
Also known as: Anchors and Sails
Devaluation of Consumer Families (DCFS) Scale
9-items scored on a 4 point likert scale from 1 (strongly disagree) to 4 (strongly agree). Total range of scores is 9-36 with higher scores indicating higher devaluation of the family.
Time frame: baseline (pre-intervention) and 6 weeks (post-intervention)
Self-Compassion Scale Score
Self-Compassion Scale (26-item), scored from 26 to 130, with higher scores indicating greater self-compassion.
Time frame: baseline (pre-intervention) and 6 weeks (post-intervention)
Caregiving Appraisal Scale Score: Agreement
Caregiving Appraisal Scale (6-item) scored from 6-30 where higher scores indicate higher appraisal.
Time frame: baseline (pre-intervention) and 6 weeks (post-intervention)
Caregiving Appraisal Scale Score: Frequency
Caregiving Appraisal Scale (23-item) scored from 23-115 where higher scores indicate more frequency of appraisal.
Time frame: baseline (pre-intervention) and 6 weeks (post-intervention)
Family Empowerment Scale Score
Family Empowerment Scale (12-item) scored from 12-60 with higher scores meaning more empowered.
Time frame: baseline (pre-intervention) and 6 weeks (post-intervention)
State Hope Scale Score
State Hope Scale (6-item) scored from 6-48 where higher scores indicate more hope
Time frame: baseline (pre-intervention) and 6 weeks (post-intervention)
Caregiving Confidence Scale (CSES-8) Score
CSES-8 scored from 1-10 with higher scores meaning more confidence
Time frame: baseline (pre-intervention) and 6 weeks (post-intervention)
Affiliate Stigma Scale Score
Affiliate Stigma Scale (22-item) scored from 22-88 where higher scores indicate increased stigma
Time frame: baseline (pre-intervention) and 6 weeks (post-intervention)
Caregiving Flexibility Score
Caregiving flexibility score (18-item) scored from 18-72 where higher scores indicate increased flexibility
Time frame: baseline (pre-intervention) and 6 weeks (post-intervention)
Feeling of Loneliness Score
Feeling of Loneliness (3-item) scored from 3-9 where higher scores indicate increased loneliness
Time frame: baseline (pre-intervention) and 6 weeks (post-intervention)
Autonomy Support Scale Score
Autonomy Support Scale (5-item) scored from 5-20 where higher scores indicate more autonomy
Time frame: baseline (pre-intervention) and 6 weeks (post-intervention)
Emotional Support Scale Score
Emotional Support Scale (6-item) scored from 6-30 where higher scores indicate increased emotional support
Time frame: baseline (pre-intervention) and 6 weeks (post-intervention)
Plan to share: No
No publications or documents are linked to this record.
Started Sep 2026 (actual). Primary completion is estimated for Jun 2027, 9 months after the start.
Of 355 non-industry interventional studies with no phase under Autistic Disorder, half reached primary completion within 26 months of starting (the median), counting those still running; a quarter within 14 and three quarters within 50. This study's planned 9 months is below that.
Counting every sponsor, half of 367 studies reached it within 26 months; a quarter within 13 and three quarters within 50.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University of Wisconsin, Madison →